Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.
Takeshi Ogata(Iwakuni Medical Center), Susumu Kanazawa(Okayama University), Yoshinobu Maeda(Okayama University Hospital), Kotaro Yoshio(Okayama University Hospital), Kuniaki Katsui(Fukuyama City Hospital), Junichi Soh(Okayama University), Katsuyuki Kiura(Okayama University Hospital), Norihisa Katayama(Okayama University), Hiroki Ihara(Tsuyama Chuo Hospital), Masahiro Kuroda(Okayama University), Shinichi Toyooka(Okayama University Hospital)
Cited by 9
Related Papers
Accurate diagnosis of musculoskeletal lesions by core needle biopsy
|Journal of Surgical Oncology|2006|162
Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
|Cancer Research|2016|128
Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
|Molecular Cancer Therapeutics|2011|126
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79